LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 356

Suchoptionen

  1. Artikel ; Online: Hair loss is a symptom of many complex medical and psychological problems.

    Rudnicka, Lidia

    Journal of the European Academy of Dermatology and Venereology : JEADV

    2023  Band 37, Heft 8, Seite(n) 1460–1461

    Mesh-Begriff(e) Humans ; Alopecia/diagnosis ; Alopecia/etiology
    Sprache Englisch
    Erscheinungsdatum 2023-11-09
    Erscheinungsland England
    Dokumenttyp Editorial
    ZDB-ID 1128828-0
    ISSN 1468-3083 ; 0926-9959
    ISSN (online) 1468-3083
    ISSN 0926-9959
    DOI 10.1111/jdv.19283
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: A ranking of treatment efficacy in alopecia areata is not possible without head-to-head studies.

    Rudnicka, Lidia / Olszewska, Malgorzata

    Journal of the European Academy of Dermatology and Venereology : JEADV

    2024  Band 38, Heft 5, Seite(n) 786–787

    Mesh-Begriff(e) Alopecia Areata/drug therapy ; Humans ; Treatment Outcome
    Sprache Englisch
    Erscheinungsdatum 2024-04-25
    Erscheinungsland England
    Dokumenttyp Letter ; Journal Article
    ZDB-ID 1128828-0
    ISSN 1468-3083 ; 0926-9959
    ISSN (online) 1468-3083
    ISSN 0926-9959
    DOI 10.1111/jdv.19964
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Buch: Atlas of trichoscopy

    Rudnicka, Lidia / Olszewska, Malgorzata / Rakowska, Adriana

    dermoscopy in hair and scalp disease

    2012  

    Verfasserangabe Lidia Rudnicka ; Malgorzata Olszewska ; Adriana Rakowska
    Schlagwörter Hair--Diseases--Diagnosis ; Scalp--Diseases--Diagnosis
    Sprache Englisch
    Umfang XIV, 507 S. : zahlr. Ill., 28 cm
    Verlag Springer
    Erscheinungsort London u.a.
    Erscheinungsland Vereinigtes Königreich
    Dokumenttyp Buch
    HBZ-ID HT017511831
    ISBN 978-1-4471-4485-4 ; 9781447144861 ; 1-4471-4485-6 ; 1447144864
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Zusatzmaterialien

    Kategorien

  4. Artikel: Trichoscopy of Androgenetic Alopecia: A Systematic Review.

    Kuczara, Agata / Waśkiel-Burnat, Anna / Rakowska, Adriana / Olszewska, Małgorzata / Rudnicka, Lidia

    Journal of clinical medicine

    2024  Band 13, Heft 7

    Abstract: ... ...

    Abstract Background
    Sprache Englisch
    Erscheinungsdatum 2024-03-28
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm13071962
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Quiz dermatologiczny

    Magdalena Maciejewska / Joanna Czuwara / Małgorzata Olszewska / Lidia Rudnicka

    Przegląd Dermatologiczny, Vol 109, Iss 6, Pp 475-

    2023  Band 476

    Schlagwörter Medicine ; R ; Dermatology ; RL1-803
    Sprache Englisch
    Erscheinungsdatum 2023-04-01T00:00:00Z
    Verlag Termedia Publishing House
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Trichoscopy Features of Allergic Contact Dermatitis of the Scalp: A Prospective Case Series.

    Makowska, Katarzyna / Golińska, Joanna / Sar-Pomian, Marta / Rudnicka, Lidia

    Dermatitis : contact, atopic, occupational, drug

    2023  Band 34, Heft 3, Seite(n) 265–268

    Mesh-Begriff(e) Humans ; Scalp ; Dermatitis, Allergic Contact/diagnosis ; Dermatitis, Allergic Contact/etiology ; Patch Tests ; Scalp Dermatoses/etiology
    Sprache Englisch
    Erscheinungsdatum 2023-01-02
    Erscheinungsland United States
    Dokumenttyp Letter
    ZDB-ID 2144723-8
    ISSN 2162-5220 ; 1532-8163 ; 1710-3568
    ISSN (online) 2162-5220 ; 1532-8163
    ISSN 1710-3568
    DOI 10.1097/DER.0000000000000832
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Autoinflammatory Keratinization Diseases-The Concept, Pathophysiology, and Clinical Implications.

    Blicharz, Leszek / Czuwara, Joanna / Rudnicka, Lidia / Torrelo, Antonio

    Clinical reviews in allergy & immunology

    2023  Band 65, Heft 3, Seite(n) 377–402

    Abstract: Recent advances in medical genetics elucidated the background of diseases characterized by superficial dermal and epidermal inflammation with resultant aberrant keratosis. This led to introducing the term autoinflammatory keratinization diseases ... ...

    Abstract Recent advances in medical genetics elucidated the background of diseases characterized by superficial dermal and epidermal inflammation with resultant aberrant keratosis. This led to introducing the term autoinflammatory keratinization diseases encompassing entities in which monogenic mutations cause spontaneous activation of the innate immunity and subsequent disruption of the keratinization process. Originally, autoinflammatory keratinization diseases were attributed to pathogenic variants of CARD14 (generalized pustular psoriasis with concomitant psoriasis vulgaris, palmoplantar pustulosis, type V pityriasis rubra pilaris), IL36RN (generalized pustular psoriasis without concomitant psoriasis vulgaris, impetigo herpetiformis, acrodermatitis continua of Hallopeau), NLRP1 (familial forms of keratosis lichenoides chronica), and genes of the mevalonate pathway, i.e., MVK, PMVK, MVD, and FDPS (porokeratosis). Since then, endotypes underlying novel entities matching the concept of autoinflammatory keratinization diseases have been discovered (mutations of JAK1, POMP, and EGFR). This review describes the concept and pathophysiology of autoinflammatory keratinization diseases and outlines the characteristic clinical features of the associated entities. Furthermore, a novel term for NLRP1-associated autoinflammatory disease with epithelial dyskeratosis (NADED) describing the spectrum of autoinflammatory keratinization diseases secondary to NLRP1 mutations is proposed.
    Mesh-Begriff(e) Humans ; Psoriasis/genetics ; Psoriasis/pathology ; Inflammation/genetics ; Mutation ; Immunity, Innate ; Keratosis ; Guanylate Cyclase/genetics ; Membrane Proteins ; CARD Signaling Adaptor Proteins/genetics ; Interleukins/genetics
    Chemische Substanzen CARD14 protein, human (EC 4.6.1.-) ; Guanylate Cyclase (EC 4.6.1.2) ; Membrane Proteins ; CARD Signaling Adaptor Proteins ; IL36RN protein, human ; Interleukins
    Sprache Englisch
    Erscheinungsdatum 2023-12-16
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 1239045-8
    ISSN 1559-0267 ; 1080-0549
    ISSN (online) 1559-0267
    ISSN 1080-0549
    DOI 10.1007/s12016-023-08971-3
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Ocular involvement in autoimmune bullous diseases.

    Kurzeja, Marta / Olszewska, Malgorzata / Grzybowski, Andrzej / Rudnicka, Lidia

    Clinics in dermatology

    2023  Band 41, Heft 4, Seite(n) 481–490

    Abstract: Autoimmune bullous diseases represent a heterogenous group of disorders caused by autoantibodies against adhesion molecules; the location of the target protein determines the level of cleft formation. The spectrum of ocular lesions in autoimmune bullous ... ...

    Abstract Autoimmune bullous diseases represent a heterogenous group of disorders caused by autoantibodies against adhesion molecules; the location of the target protein determines the level of cleft formation. The spectrum of ocular lesions in autoimmune bullous diseases can range from mild symptoms to severe involvement with sight impairment and even, in some cases, blindness. In pemphigus vulgaris, the prevalence of ocular involvement has been reported to be between 7% and 26%. The most common clinical sign of ocular pemphigus vulgaris is bilateral conjunctivitis with hyperemia. Ocular involvement also occurs in 41% to 70% of patients with paraneoplastic pemphigus. The main ocular manifestations are bilateral cicatrizing conjunctivitis with symblepharon formation, and shortening of the fornices. In mucous membrane pemphigoid, ocular involvement is seen in 61% to 70% of patients; the most frequent ocular finding is cicatricial conjunctivitis. Patients with autoimmune bullous diseases having common ocular involvement should be assessed by an ophthalmologist to avoid serious complications. Diagnostic procedures and treatment require multidisciplinary care based on the close cooperation between dermatologists and ophthalmologists.
    Mesh-Begriff(e) Humans ; Pemphigus/drug therapy ; Autoimmune Diseases/diagnosis ; Skin Diseases, Vesiculobullous/complications ; Skin Diseases, Vesiculobullous/diagnosis ; Pemphigoid, Benign Mucous Membrane/complications ; Pemphigoid, Benign Mucous Membrane/diagnosis ; Pemphigoid, Benign Mucous Membrane/drug therapy ; Conjunctivitis
    Sprache Englisch
    Erscheinungsdatum 2023-08-14
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 1064149-x
    ISSN 1879-1131 ; 0738-081X
    ISSN (online) 1879-1131
    ISSN 0738-081X
    DOI 10.1016/j.clindermatol.2023.08.007
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel ; Online: Treatment of diseases associated with non-cicatricial alopecia

    Lidia Rudnicka / Agnieszka Kaczorowska

    Przegląd Dermatologiczny, Vol 108, Iss 6, Pp 504-

    2022  Band 516

    Abstract: Alopecia (loss of volume or complete loss of hair) can be a symptom of many diseases. In some cases it is a symptom of a local pathology limited to the scalp, in others it is a dermatological symptom of a systemic pathology. In almost every case, ... ...

    Abstract Alopecia (loss of volume or complete loss of hair) can be a symptom of many diseases. In some cases it is a symptom of a local pathology limited to the scalp, in others it is a dermatological symptom of a systemic pathology. In almost every case, alopecia has a significant impact on the quality of life and may cause limitations in professional, social and private life. The management of alopecia is based on a preceding comprehensive medical differential diagnosis, which significantly exceeds basic dermatological diagnostic procedures. This article presents the basic information on therapeutic methods that can be used in selected diseases associated with non-cicatricial alopecia: androgenetic alopecia, senile alopecia, anagen effluvium, telogen effluvium, alopecia areata, non-cicatricial alopecia secondary to systemic lupus erythematosus, trichotillomania, traction alopecia, pressure alopecia, lipedematous scalp and lipedematous alopecia.
    Schlagwörter non-cicatricial alopecia ; treatment of hair diseases ; androgenic alopecia ; alopecia areata ; Medicine ; R ; Dermatology ; RL1-803
    Sprache Englisch
    Erscheinungsdatum 2022-03-01T00:00:00Z
    Verlag Termedia Publishing House
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review.

    Papierzewska, Małgorzata / Waśkiel-Burnat, Anna / Rudnicka, Lidia

    Clinical drug investigation

    2023  Band 43, Heft 5, Seite(n) 325–334

    Abstract: Background and objectives: Janus kinase (JAK) inhibitors are emerging as a therapeutic option for alopecia areata. The risk of potential adverse events is currently debated. In particular, several safety data for JAK inhibitors are extrapolated from a ... ...

    Abstract Background and objectives: Janus kinase (JAK) inhibitors are emerging as a therapeutic option for alopecia areata. The risk of potential adverse events is currently debated. In particular, several safety data for JAK inhibitors are extrapolated from a single study in elderly patients with rheumatoid arthritis treated with tofacitinib or adalimumab/etanercept as a comparator. The population of patients with alopecia areata is clinically and immunologically different from persons with rheumatoid arthritis and tumor necrosis factor (TNF) inhibitors are not effective in these patients. The objective of this systematic review was to analyze available data on the safety of various JAK inhibitors in patients with alopecia areata.
    Methods: The systematic review was performed according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A literature review was performed by searching PubMed, Scopus and EBSCO databases with the last search on March 13, 2023.
    Results: In total, 36 studies were included. The frequency and odds ratio (OR) for most common adverse events versus placebo were: for baricitinib hypercholesterolemia (18.2% vs 10.5%, OR = 1.9) and headache (6.1% vs 5.1%, OR = 1.2), for brepocitinib elevated creatinine level (27.7% vs 4.3%, OR = 8.6) and acne (10.6% vs 4.3%, OR = 2.7), for ritlecitinib acne (10.4% vs 4.3%, OR = 2.6) and headache (12.5% vs 10.6%, OR = 1.2) and for deuruxolitinib headache (21.4% vs 9.1%, OR = 2.7) and acne (13.6% vs 4.5%, OR = 3.3). The respective numbers for upper respiratory infections were: baricitinib (7.3% vs 7.0%, OR = 1.0) and brepocitinib (23.4% vs 10.6%, OR = 2.6); for nasopharyngitis: ritlecitinib (12.5% vs 12.8%, OR = 1.0) and deuruxolitinib (14.6% vs 2.3%, OR = 7.3).
    Conclusions: The most common side effects of JAK inhibitors in patients with alopecia areata were headache and acne. The OR for upper respiratory tract infections varied from over 7-fold increased to comparable to placebo. The risk of serious adverse events was not increased.
    Mesh-Begriff(e) Humans ; Aged ; Janus Kinase Inhibitors/adverse effects ; Alopecia Areata/drug therapy ; Alopecia Areata/chemically induced ; Protein Kinase Inhibitors/adverse effects ; Arthritis, Rheumatoid/drug therapy ; Alopecia/drug therapy
    Chemische Substanzen Janus Kinase Inhibitors ; baricitinib (ISP4442I3Y) ; Protein Kinase Inhibitors
    Sprache Englisch
    Erscheinungsdatum 2023-05-03
    Erscheinungsland New Zealand
    Dokumenttyp Systematic Review
    ZDB-ID 1220136-4
    ISSN 1179-1918 ; 0114-2402 ; 1173-2563
    ISSN (online) 1179-1918
    ISSN 0114-2402 ; 1173-2563
    DOI 10.1007/s40261-023-01260-z
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang